inHEART RECEIVES FDA CLEARANCE FOR ADVANCED AI-DRIVEN SOFTWARE MODULE THAT OPTIMIZES THE CREATION OF 3D MODELS OF THE HEART

Solution uses fully automated AI segmentation to generate inHEART’s digital twin of the heart with greater speed and efficiency CAMBRIDGE, Mass. and BORDEAUX, France, March 19, 2024 /PRNewswire/ — inHEART, a privately-held medical device company delivering the world’s most advanced,…